Skip to main content
SpringerLink
Log in

Mechanisms of Molecular Carcinogenesis – Volume 2

  • Book
  • © 2017

Overview

Editors:
  1. Johannes Haybaeck

    1. Department of Pathology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Offers a broad and concise understanding on various tumor entities

  • Volume 2 presents novel strategies for biomarker identification

  • Describes emerging diagonstic techniques

  • Discusses individualized treatment strategies

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 chapters)

  1. Front Matter

    Pages i-viii
    Download chapter PDF

  2. Molecular Classification of Breast Cancer

    • Iva Brčić, Marija Balić
    Pages 1-22

  3. Nonmelanoma Skin Cancer Actinic Keratosis and Squamous Cell Carcinoma

    • Birgit Aigner, Franz Legat, Wolfgang Weger
    Pages 23-39

  4. Molecular Pathogenesis of Bone Tumours

    • Maria A. Smolle, Johannes Haybaeck
    Pages 41-63

  5. Molecular and Cellular Mechanisms of Carcinogenesis in the Large Bowel

    • Iva Brčić, Catarina Callé, Cord Langner
    Pages 65-82

  6. Pancreatic Carcinogenesis

    • V. Taucher, Johannes Haybaeck
    Pages 83-118

  7. Hepatocellular Carcinogenesis

    • Nicole Golob-Schwarzl, Sonja Kessler, Johannes Haybaeck
    Pages 119-140

  8. Neuroendocrine Tumorigenesis

    • Nadine Gantenbein, Johannes Haybaeck
    Pages 141-146

  9. Molecular Etiopathogenesis of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue

    • Alexander JA Deutsch, Katharina Troppan, Karoline Fechter, Peter Neumeister
    Pages 147-169

  10. Molecular Pathogenesis of Prostate Cancer

    • Maria A. Smolle, Johannes Haybaeck, Martin Pichler
    Pages 171-189

  11. Molecular Carcinogenesis of Urinary Bladder Cancer

    • Rita Seeböck, Johannes Haybaeck
    Pages 191-205

  12. Molecular Carcinogenesis in Gynecologic Neoplasias

    • Elisabeth Smolle
    Pages 207-231

  13. Potential and Challenges of Liquid Biopsies

    • Amin El-Heliebi, Ellen Heitzer, Thomas Kroneis, Shukun Chen, Christoph Haudum, Julia Fuchs
    Pages 233-261

  14. Computational Pathology

    • Peter J. Schüffler, Qing Zhong, Peter J. Wild, Thomas J. Fuchs
    Pages 263-279

  15. In Vitro Three-Dimensional Cell Cultures as Tool for Precision Medicine

    • Alessandra Silvestri, Dirk Schumacher, Maxine Silvestrov, Reinhold Schäfer, Christoph Reinhard, Jens Hoffmann et al.
    Pages 281-313

  16. Stratifying Cancer Therapies by Molecular Interactions and Imaging

    • Myria Galazi, Gregory Weitsman, James Monypenny, Oana Coban, Hanna Milewicz, Valenti Gomez et al.
    Pages 315-358

  17. Modelling Molecular Mechanisms of Cancer Pathogenesis: Virtual Patients, Real Opportunities

    • Hans Lehrach, Thomas Kessler, Lesley Ogilvie, Moritz Schütte, Christoph Wierling
    Pages 359-374
Back to top

Keywords

About this book

Together with Volume 1, this book provides an inclusive overview of the molecular and cellular mechanisms of carcinogenesis and offers comprehensive insights into related clinical and therapeutic aspects. 

This second volume complements the first by presenting and concisely explaining the carcinogenesis of various tumor entities such as non-melanoma skin cancers, bone and soft tissue tumors, pancreatic cancers, hepatocellular cancer and neuroendocrine tumors. As in volume one, each chapter illuminates the similarities and dissimilarities of changed signaling pathways in the different organ systems and depicts potential therapeutic strategies. The focus of volume two lies on the presentation of modern molecular biological techniques for diagnosis, as well as strategies for biomarker identification and validation. Furthermore, it discusses potential therapeutic targets and individualized treatment strategies, offering a valuable resource for all basic scientists and medical researchers interested in translational cancer research.




Editors and Affiliations

  • Department of Pathology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany

    Johannes Haybaeck

About the editor

Prof. Johannes Haybaeck is a professor of Pathology at the Department of Pathology, Medical Faculty of the University of Magdeburg, Germany. He is a board certified pathologist and neuropathologist who is also specialized in molecular biology. Prof. Haybaeck received his first degree in Medicine at Innsbruck University, Austria, prior to further studies at the University of Zurich, Innsbruck and Salzburg. He received his PhD degree at the Mathematical and Natural Science Faculty of the University of Zurich. Since 2010, he has led his own research group and has been a consultant for pathology and neuropathology.  In 2011, he was nominated as Vice Chair, and since 2014, he has held the title of Chairman of the Department of Neuropathology at the Medical University of Graz, Austria. He was elected as Founding Coordinator for Cancer Research, Education and Training of the Comprehensive Cancer Center (CCC) Graz for two periods. In 2016, he was nominated as Full Professor and Head of the Department of Pathology at Magdeburg University Hospital in Germany. In his capacity as a surgical pathologist and neuropathologist, he is confronted with diagnostic questions on a daily basis. Accordingly, his research focuses on the cellular and molecular mechanisms driving carcinogenesis. Together with his coworkers in Magdeburg and Graz, he is constantly engaged in the development of novel models mimicking the human situation in order to establish prognostic and predictive biomarkers and to generate novel therapies.



Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation